Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

FDA Approved Indication: Retapamulin: For adults and pediatric patients aged nine months and older for impetigo (up to 100 cm2 of total area in adults or 2% total body surface area in pediatric patients) due to methicillin-susceptible Staphylococcus aureus or Streptococcus pyogenes.

Drug Criteria & Outcomes: Retapamulin (Altabax™) Formulary Evaluation